[What is assured in treatment with beta receptor blockaders?].
D000083:Acetanilides / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000526:Alprenolol / Q000627:therapeutic use; D000605:Amino Alcohols / Q000627:therapeutic use; D003408:Cresols / Q000627:therapeutic use; D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007545:Isoproterenol / Q000627:therapeutic use*; D010096:Oxprenolol / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy; D010673:Pheochromocytoma / Q000188:drug therapy; D010869:Pindolol / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011437:Propylamines / Q000627:therapeutic use; D013329:Structure-Activity Relationship
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D003408:Cresols; D011437:Propylamines; D010096:Oxprenolol; D000526:Alprenolol; D011433:Propranolol; D010869:Pindolol; D007545:Isoproterenol
Was ist gesichert in der Behandlung mit  -Receptorenblockern.